← Back
$BIOA All transactions

BioAge Labs, Inc.

▼ SELL 10b5-1 Plan

$ Value

$702K

Shares

68,897

Price

$10

Filed

Dec 5

Insider

Name

RUBIN PAUL D

Title

Chief Medical Officer

CIK

0001210905

Roles

Officer

Transaction Details

Transaction Date

2025-12-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.96 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote | This option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024.

Filing Info

Accession No.

0001210905-25-000004

Form Type

4

Issuer CIK

0001709941

RUBIN PAUL D's History

Date Ticker Type Value
2026-04-01 BIOA M $22K
2026-04-01 BIOA M $22K
2026-04-01 BIOA $157K
2026-04-01 BIOA M $0
2026-04-01 BIOA M $0
2026-03-02 BIOA M $22K
2026-03-02 BIOA M $13K
2026-03-02 BIOA $151K
2026-03-02 BIOA M $0
2026-03-02 BIOA M $0

Other Insiders at BIOA (90d)

Insider Bought Sold Last
GOLDSTEIN DOV A MD
Chief Financial Officer
2026-03-01
RUBIN PAUL D
Chief Medical Officer
$447K 2026-04-01
Barton Shane
Principal Accounting Officer
2026-02-17
Fortney Kristen
Chief Executive Officer
2026-02-17
Morgen Eric
Chief Operating Officer
2026-02-17